- Russia-Oman trade jumps 22-fold to $1.5 billion, Shoigu says
- Magnitude 7 earthquake in Tibet kills 16 and injures dozens
- Japan posts 536.6 billion yen trade deficit in September
- SGU urges risk-based breast cancer screening in Africa
- Abu Dhabi Crown Prince arrives in Athens for official visit
- Korean exports double to $61.6 billion on chip shipments
- Türkiye targets $70 billion in tourism revenue in 2027
- Russian, Chinese scientists develop ultrasonic welding method
/ Today, Dematic announced the global launch of its Noise Reduction Portfolio, a comprehensive solution to address loud work environments across supply chain facilities. The offering includes before and after 3D noise mapping audits throughout a facility, enhanced rollers, slats,
The complete Biomethane process eliminates flares and reduces carbon intensity.
Tournament Benefited the Official Royal Charities of the Prince and Princess of Wales
Extension of Commercial Offtake Agreement through December, 2026; Ocean Partners to Purchase 1M Shares of Common Stock of DynaResource, Inc. at $5 / Share
Extension of Commercial Offtake Agreement through December, 2026; Ocean Partners to Purchase 1M Shares of Common Stock of DynaResource, Inc. at $5 / Share
INNIO’s Jenbacher brand received the COGEN Europe Market Development Award 2023 in recognition of four major projects across the cogeneration sector. – The COGEN Europe event highlighted the latest trends from the energy world in the presence of industry representatives,
/ NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies.
/ The Oligonucleotide Therapeutics Society (OTS) is excited to bring together those in the field of oligonucleotide therapeutics for its 19th Annual Oligo Meeting. Anyone interested in oligonucleotide therapeutics is welcome to join the event, which will be held virtually
Web3: Charting the Internet’s Next Economic and Cultural Frontier explains how the new Web will usher in a new era of possibilities and challenges.
/ Moolec Science SA ((NASDAQ:MLEC) “Company”; “Moolec”), a science-based food ingredient company focused on producing animal proteins in plants through Molecular Farming technology, announced today an outstanding achievement in its Meat Replacements Program for the Soybean platform, as its new
As a part of their expansion plans, GammaStack has introduced a new set of iGaming offerings with an aim to reach new geographies.
SourceLess, a leading technology company, is set to participate in the highly anticipated Financial Intelligence event, where Alexandru Nichita, the Chief Operating Officer of SourceLess, will deliver a keynote speech on the digitalization of Romania. With a vast experience in
Playbux.co and iQIYI Announce Groundbreaking Partnership, Revolutionizing the Streaming Landscape by Launching the Largest “Watch to Win” WEB3 Project in the World
Transforming the Content Management Process Across Organizations – Faster, Better, and Smarter
/ StrikeX Technologies Ltd. welcomes Laurence Booth and Simon Campbell from CMC Markets PLC to their board of directors. Laurence’s and Simon’s vast experience and expertise will be instrumental to StrikeX as the company continues to grow.
Leading the Way in Crypto Security, NOW Wallet Introduces Unparalleled Protection and User-Friendly Features
/ On Jan. 8, 2023, Dunhill Ventures, a world leader in diversified investments, held a landmark event at this year’s World Economic Forum (WEF) in Davos, showcasing a portfolio of companies from industries as diverse as impact investing, blockchain, fintech,
Multi-Billion-Dollar Global Sports Brand’s Motto, “Play Your Part,” at the Pitti Games
The tech-enabled feature to connect PUMA’s online customers with offline stores allows associates to provide a personalized shopping experience.
/ GeneTex, a multinational antibody manufacturing company, is leveraging its recombinant monoclonal antibody production platform to produce best-in-class biomedical research reagents. The specificity of these new antibodies is established through meticulous in-house validation testing based on knockdown/knockout methodologies complemented by


